UNITY BIOTECHNOLOGY, INC.
Profile
Company Names
UNITY BIOTECHNOLOGY, INC.
CENEXYS, INC.
FORGE INC
Addresses
3280 BAYSHORE BOULEVARD, BRISBANE, CA 94005
1700 OWENS STREET, SUITE 535, SAN FRANCISCO, CA 94158
1471 1/2 HAVENHURST DRIVE, LOS ANGELES, CA 90046
Phone Numbers
(415) 328-5504
(415) 888-3731
(818) 587-4529
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, BIOTECHNOLOGY, OTHER
Year Incorporated:
2009
State Incorporated:
DE
Total Amount Raised:
$208,572,102.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2018-03-15
$55,049,948.00
$60,000,000.00
$4,950,052.00
Equity
4
2016-10-14
$151,230,099.00
$177,598,051.00
$26,367,952.00
Equity
3
2013-07-03
$2,041,555.00
$6,083,265.00
$4,041,710.00
Equity
2
2009-04-23
$250,000.00
$1,000,000.00
$750,000.00
Debt
1
2009-04-22
$500.00
$500.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAUL
BERNS
DIRECTOR
KRISTINA
BUROW
DIRECTOR
KILIMANJARO ENERGY, INC.
| LIMERICK BIOPHARMA INC
| RECEPTOS, INC.
| TRELYS, INC.
| CENEXYS, INC.
| LYCERA CORP
| ARCH VENTURE FUND VIII, L.P.
| AGBIOME, LLC
| METACRINE, INC.
| SIENNA LABS, INC.
| SCHOLAR ROCK LLC
| UNITY BIOTECHNOLOGY, INC.
| ARCH VENTURE FUND IX, L.P.
| BORAGEN, INC.
| SIENNA BIOPHARMACEUTICALS, INC.
| SCHOLAR ROCK HOLDING CORP
| GOSSAMER BIO, INC.
| VIR BIOTECHNOLOGY, INC.
| BEAM THERAPEUTICS INC.
| VIVIDION THERAPEUTICS, INC.
| ARCH VENTURE FUND X, L.P.
| ARCH VENTURE FUND X OVERAGE, L.P.
| BOUNDLESS BIO, INC.
| ARCH VENTURE FUND XI, L.P.
| TREELINE BIOSCIENCES, INC.
| ARCH VENTURE FUND XII, L.P.
| NEUMORA THERAPEUTICS, INC.
| MIRADOR THERAPEUTICS, INC.
| AUTOBAHN THERAPEUTICS, INC.
| METSERA, INC.
NATHANIEL
DAVID
EXECUTIVE OFFICER, DIRECTOR
TROY
FOSTER
EXECUTIVE OFFICER
KEITH
KLEIN
EXECUTIVE OFFICER
KEITH
LEONARD
EXECUTIVE OFFICER, DIRECTOR
ROBERT
NELSEN
DIRECTOR
FORGE INC
| RECEPTOS, INC. (F.K.A. RECEPTOR PHARMACEUTICALS INC.)
| AGIOS PHARMACEUTICALS INC
| KILIMANJARO ENERGY, INC.
| NEUROGESX INC
| KYTHERA BIOPHARMACEUTICALS INC
| SYROS PHARMACEUTICALS, INC.
| FATE THERAPEUTICS INC
| CENEXYS, INC.
| JUNO THERAPEUTICS, INC.
| BELLEROPHON THERAPEUTICS LLC
| FARADAY PHARMACEUTICALS, INC.
| SAPPHIRE ENERGY, INC.
| UNITY BIOTECHNOLOGY, INC.
| ARIVALE INC.
| SIENNA BIOPHARMACEUTICALS, INC.
| GOSSAMER BIO, INC.
| VIR BIOTECHNOLOGY, INC.
| BEAM THERAPEUTICS INC.
| GRAIL, INC.
| APEX NEURO HOLDINGS, INC.
| NUTCRACKER THERAPEUTICS, INC.
| SANA BIOTECHNOLOGY, INC.
| INSITRO, INC.
| NATIONAL RESILIENCE, INC.
| MEDICAL CREATIONS, INC.
| NEUMORA THERAPEUTICS, INC.
| RIPPL CARE, INC.
| SEAPORT THERAPEUTICS, INC.
CAMILLE
SAMUELS
DIRECTOR
TAMARA
TOMPKINS
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-03-15
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

